CapitolRadar tracks every publicly disclosed RXST trade by US congress members and corporate insiders: 0 disclosed trades (0 buys, 0 sells) by 0 tracked traders. Updated daily from official filings.
Want a ping when Congress buys RXST? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
RxSight, Inc. (RXST) — Healthcare · Medical - Devices, market cap about $0.2B.
Cluster watch: 4 distinct tracked traders disclosed buying RXST in the last 45 days: Wilterding Mark (officer: Chief Financial Officer), Weinberg Eric (officer: See remarks), Kurtz Ronald M MD (officer: Chief Medical Officer), Goldshleger Ilya (officer: Chief Operating Officer).
CapitolRadar signal history
NEW PICK 2026-09-16
RxSight officer Eric Weinberg disclosed buying about $152,629 of RXST, alongside purchases by three other company officers. The trade fell short mainly because its listed date is in the future and no filing excerpt was provided, so the purchase could not be verified. An official filing confirming the date, buyer, and open-market purchase details would have given the panel evidence to reconsider.
NEW PICK 2026-09-10
RxSight CFO Mark Wilterding disclosed a roughly $1.65 million stock purchase, joining three other tracked company buyers in 45 days. The panel passed mainly because Wilterding has no verified trading history, so the large purchase is an unproven signal. A verified record showing that his prior open-market buys consistently outperformed SPY would have strengthened the case enough to reconsider the verdict.
About RxSight, Inc.
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part…
Frequently asked questions
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.